Get App Open
In App
Lending
Lending
Open App
you are here:
Success
Alert
Please select a Day.
Info

Aarti Drugs Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

60/100
493.95
-13.80 (-2.72%)

As on 24 Oct, 2025 | 03:56

Open Trading A/c
Day Range
491.80
509.70
L H
52 Week Range
312.00
564.05
L H
Volume
94,285
*
i

* BSE Market Depth (24 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
4 493.50 496.00 16
11 493.15 497.00 22
2 493.00 502.00 100
1 492.30 512.00 1
1 491.50 515.00 53
0 Total Total 0
Bid / Ask
0.00 / 0.00
60/100
494.70
-12.75 (-2.51%)

As on 24 Oct, 2025 | 04:01

Open Trading A/c
Day Range
493.25
507.50
L H
52 Week Range
312.50
574.95
L H
Volume
4,533
*
i

* BSE Market Depth (24 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
4 493.50 496.00 16
11 493.15 497.00 22
2 493.00 502.00 100
1 492.30 512.00 1
1 491.50 515.00 53
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
65% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, Average Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 507.75
          Previous Close 507.75
          Volume 94,285.00
          Value (Lacs) 465.72
            VWAP 498.04
          Beta
          Mkt Cap (Rs. Cr.) 4,508
          High 509.70
          Low 491.80
          UC Limit 609.30
          LC Limit 406.20
          52 Week High 564.05
          52 Week Low 312.00
          Face Value 10.00
          All Time High 1,026.95
          All Time Low 1.64
          20D Avg Volume 141,535
          20D Avg Delivery(%) 43.58
          Book Value Per Share 139.96
          Dividend Yield 0.20
          TTM EPS See historical trend 20.69 (+24.05% YoY)
          TTM PE See historical trend 23.87 (Average PE)
          P/B See historical trend 3.53 (Low P/B)
          Sector PE 39.93

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          60/100
          Superior Financial Strength, Average Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 12.43% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 55.48% to 54.72% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          CHART PATTERNS Super PRO

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          8 out of 16 years Aarti Drugs has given positive returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 18.54% (2019) 7.55% -20.03% (2009) -9.04% -0.74%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Aarti Drugs

          What's your call on Aarti Drugs today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          07 May, 2025

          Graviton Research Capital Llp

          Qty 803687 Price 393.62 % Traded 0.83
          07 May, 2025

          Graviton Research Capital Llp

          Qty 803477 Price 393.1 % Traded 0.82

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Aarti Drugs 493.95 -2.72 4,508.28 23.87 3.53 12.28 1.20 168 2,387 0.45
          Sun Pharma 1,699.00 0.54 407,647.01 39.30 5.90 15.13 -7.63 10,980 52,578 0.03
          Divis Labs 6,593.00 0.42 175,023.43 75.90 12.76 14.63 15.11 2,191 9,360 0.00
          Cipla 1,584.40 -3.69 127,982.40 23.73 4.51 16.90 6.65 5,291 27,547 0.00
          Torrent Pharma 3,581.40 -0.90 121,210.85 60.55 16.15 25.17 7.83 1,911 11,516 0.40

          About the Company

          Aarti Drugs Ltd. is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. They manufacture drugs in therapeutic segments such as anti-arthritis, anti-fungal, antibiotics, anti-diabetic, anti-cholinergic, sedatives, anti-depressant, anti-diarrhea and anti-inflammatory. Their product list includes active pharmaceuticals ingredients (API) and steroids , pharma intermediates for irbesartan, Zolpidem Tartrate, Tamsulosin HCL, Leflunomide and Levocetirizine, Speciality Chemicals such as benzene sulphonyl chloride, benzene sulphonamide, diphenyl sulphone, N-ethyl toluene sulphonamide, ethyl toluene sulphonate, para chloro benzene sulphonamide, benzene sulfonyl hydrazide and many more. R&D programs of the company is focused on new products amongest non-steroidal NSAID compounds, antiparasitic, calciun antagonist, antianginal, antidiabetics, antdepressant and many more. The company has also planned to work on agro chemicals.
          {"success":1,"data":{"address":{"address1":"Plot No. 198, M.I.D.C.,","address2":",","city":"Palghar District","state":"Maharashtra","pincode":"401506","telephone1":"24072249","telephone2":"24019025","fax1":"24073462","fax2":"25653234","email":"investorrelations@aartidrugs.com","web":"http:\/\/www.aartidrugs.co.in"},"management":[{"name":"Chandrakant V Gogri","designation":"Chairman Emeritus"},{"name":"Prakash M Patil","designation":"Chairman & M.D & CEO"},{"name":"Rashesh C Gogri","designation":"Managing Director"},{"name":"Harshit M Savla","designation":"Joint Managing Director"},{"name":"Harit P Shah","designation":"Executive Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524348","nseId":"AARTIDRUGS","series":"EQ","isinid":"INE767A01016"}}}
          • Registered Office

          • Registrars

          • Management

            • Chandrakant V Gogri

              Chairman Emeritus

            • Prakash M Patil

              Chairman & M.D & CEO

            • Rashesh C Gogri

              Managing Director

            • Harshit M Savla

              Joint Managing Director

            • Harit P Shah

              Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524348

            • NSE:

              AARTIDRUGS

            • Series

              EQ

            • ISIN

              INE767A01016